WaveMan
WaveMan · Company
UEEC · United Health Products, Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

UEEC United Health Products (UEEC) Insider Trading, Ownership & Congress Trades

Medical Devices · Orthopedic, prosthetic & surgical appliances & supplies · CIK 0001096938
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter

United Health Products insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

No insider purchases or sales are on record for United Health Products, Inc. in the period covered. Source: SEC Form 4 filings, as of 2026-10-28.

Insider
Filed
Shares
Value
Since filing
Chief Executive Officer
BUY
2025-04-09 SECtraded 2025-04-08
32,000
$7.7K
-85.0%
Context
  • 12 earlier Form 4 trades (code P or S) here by this insider (3 buys, 9 sales), the last on Mar 31, 2025.
  • -29.3% median (-38.7% mean) 90-day return after 3 previous buys.
  • The trade is 2.9% of the 1,104,671 shares held after it.
  • No other insider bought within 30 days.
Insider activity: Chief Executive Officer Thom Brian David bought about $7.7K of UEEC on Apr 8, 2025, the largest insider purchase at the company since 2022.
Chief Executive Officer
BUY
2025-04-02 SECtraded 2025-03-31
18,000
$4.7K
-86.1%
Context
  • 11 earlier Form 4 trades (code P or S) here by this insider (2 buys, 9 sales), the last on May 12, 2023.
  • -27.1% median (-27.1% mean) 90-day return after 2 previous buys.
  • The trade is 1.7% of the 1,072,671 shares held after it.
  • No other insider bought within 30 days.
Insider activity: Chief Executive Officer Thom Brian David bought about $4.7K of UEEC on Mar 31, 2025, the largest insider purchase at the company since 2022.
Chief Executive Officer
SELL
2023-05-17 SECtraded 2023-05-12
300,000
$57.0K
-79.2%
Context
  • 10 earlier Form 4 trades (code P or S) here by this insider (2 buys, 8 sales), the last on Dec 23, 2022.
  • -27.1% median (-27.1% mean) 90-day return after 2 previous buys.
  • The trade is 28.4% of the 1,054,671 shares held after it.
  • No other insider sold within 30 days.
Insider activity: Chief Executive Officer Thom Brian David sold about $57.0K of UEEC on May 12, 2023.
Chief Executive Officer
SELL
2023-01-17 SECtraded 2022-12-23
201,400
$42.3K
-84.4%
Context
  • 9 earlier Form 4 trades (code P or S) here by this insider (2 buys, 7 sales), the last on Dec 21, 2022.
  • -27.1% median (-27.1% mean) 90-day return after 2 previous buys.
  • The trade is 29.0% of the 695,296 shares held after it.
  • No other insider sold within 30 days.
Insider activity: Chief Executive Officer Thom Brian David sold about $42.3K of UEEC on Dec 23, 2022.
Chief Executive Officer
SELL
2023-01-17 SECtraded 2022-12-21
98,600
$22.7K
-84.4%
Context
  • 8 earlier Form 4 trades (code P or S) here by this insider (2 buys, 6 sales), the last on Jun 6, 2022.
  • -27.1% median (-27.1% mean) 90-day return after 2 previous buys.
  • The trade is 14.2% of the 695,296 shares held after it.
  • No other insider sold within 30 days.
Insider activity: Chief Executive Officer Thom Brian David sold about $22.7K of UEEC on Dec 21, 2022.
20 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Showing the latest few. to see 15 more transactions and use the screener and CSV export. We store only your email; there is no password.
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch UEEC

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-34.4%12M
-47%-6%+35%+75%2025-102025-122026-022026-042026-062026-082026-10
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns UEEC: institutional holders (13F)

13F holdings, latest reported quarter
SEC 13F
No reported 13F holders

No fund above the reporting threshold listed this stock last quarter. That is a fact, not missing data.

Congress trades in UEEC

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

UEEC planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
Each figure here is a federal filing, dated the day it went public, so you can test what was knowable then.
Same sector, ranked by filing activity
Sector by SEC SIC code

UEEC financials

Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$0
four quarters, 2025-07-01 to 2026-06-30
Net margin, TTM
n/a
revenue under $1M, the ratio says nothing
Free cash flow, TTM
n/a
capex not filed for the four quarters
Debt to equity
n/a
equity is zero or negative, the ratio has no meaning
Cash flow to debt
-0.90x
TTM operating cash flow over long-term 2025-09-30 (9 months older than the period end) plus current 2019-03-31 (88 months older than the period end)
Return on equity
n/a
average equity is zero or negative
Return on assets
-863.4%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
n/a
tax provision or pre-tax income not filed for the four quarters
Return on capital employed
n/a
capital employed is zero or negative
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Enterprise value
$10.8M
market value at close 2026-10-27 on 2026-08-14 shares, plus long-term 2025-09-30 (9 months older than the period end) plus current 2019-03-31 (88 months older than the period end), minus cash 2023-03-31
FCF yield
n/a
capex not filed for the four quarters
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Revenue$0$0$0$37.5K
Gross profitn/an/a$0$18.9K
Operating income-$2.3M-$2.0M-$2.4M-$2.8M
Net income-$2.7M-$2.0M-$2.6M-$1.7M
EPS (diluted)-0.01-0.01-0.01n/a
Operating cash flow-$1.2M-$1.2M-$2.2M-$619.7K
Cashn/an/an/a$13.4K
Buybacksn/an/a$0$50.0K
SEC XBRL, fiscal years, as known on 2026-10-28

UEEC Stock Sonar score 2/7 axes

Find similar shapesCompare
Financial health
32
Inputs
  • Debt to equityequity is zero or negative, the ratio has no meaning
  • Cash flow to debt-0.90x · 32 pct, sector of 150
Risk and compliance
84
Inputs
  • Short interest, % of floatno short interest or no free float on file
  • Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
  • EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
  • New text in Risk Factors, latest 10-K+4.6% · 84 pct, sector of 198
5 not measured: Profitability, Growth, Insider conviction, Institutional and government, US patents
  • Profitability needs 2 of 4 inputs, 1 present: average equity is zero or negative; capital employed is zero or negative; tax provision or pre-tax income not filed for the four quarters
  • Growth needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
  • Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
  • Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

2 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing